Chronic Disease
Featured Topics
Lead story
Other featured articles
-
Latinos Are More Likely to Die From COVID-19, Underlining Racial and Ethnic Disparities in Outcomes
Though the study of racially diverse Medicaid patients indicated disproportionate risk among Latinos, USC researchers say it can’t be explained by higher rates of poverty or underlying health factors like obesity.
Posted in -
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
A new white paper published by the USC Schaeffer Center focuses on multi-cancer, early detection, (MCED) blood-based tests as one solution to reduce disparities in late-stage cancer diagnosis among minority populations.
Posted in -
Measuring Real-World Effectiveness and Value
Precision therapies are often approved based on small trials, in specialized settings, and using biomarkers as endpoints. Thus, despite their potential high cost, the evidence of value is lacking which makes real-world evidence crucial.
Posted in -
Leveraging Precision Medicine to Meet Patient Needs
Precision medicine promises to reduce adverse side effects and time-consuming trial and error processes, but many patients do not know what it is and providers struggle to leverage it effectively.
Posted in
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Our Experts On Chronic Disease
Our Work In Chronic Disease
-
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years.
Categorized in -
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves
Use of direct oral anticoagulants gradually increased since 2011, with a significant upward in trend after a stay-at-home order related to COVID-19.
Categorized in -
Congress Should End Dialysis Companies’ Third-Party Games with Insurance Coverage
A new op-ed in STAT highlights practices by dialysis facilities where they try to push patients into individual market plans by financing patients’ premiums for those plans
-
How Sick Is My Cohort of Patients? A General Approach to Identify Chronic Conditions
This presentation discusses a SAS(r) macro that applies Chronic Conditions Warehouse-like rules to any data set either from insurance claims, or electronic health records (EHR) containing a full picture of diagnoses and procedures from patient medical visits.
Categorized in -
Association Between Exenatide Use and Incidence of Alzheimer’s Disease
Exenatide use is associated with a reduced incidence of AD among Medicare beneficiaries aged 65 years or older with type II diabetes.
Categorized in -
Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability
Is an intensive lifestyle intervention for type 2 diabetes associated with long-term health care use and Medicare spending?
Categorized in